ArticleCancer medicine2020

Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration-resistant prostate cancer: Real-world experience in the Southeast Asian cohort.

Jasmine Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.